Skip to content
Veerhealth Care logo

Veerhealth Care

511523 BSE
Price unavailable

Veerhealth Care (VEERHEALTH) share price was ₹48.88 at the 28 Oct 2026 close; market capitalisation ₹97.74 Cr; P/E (TTM) 63.48; sector Healthcare. The share price rose 171.4% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Jun 2026 quarter, revenue rose 455.2% year on year to ₹24.93 Cr and net profit was ₹1.23 Cr, against ₹0.24 Cr a year earlier (compared with Jun 2025). Promoters held 31.88% of Veerhealth Care in Sep 2026, down 0.03 percentage points from Jun 2026. Its Tapetide Score is 58/100 (Good) as of 28 Oct 2026.

Close 28 Oct 2026 ₹48.88 +30.84 +170.95% 1Y

Key Fundamentals

MicrocapPharmaceuticals & BiotechnologyHealthcare
Market Cap
₹97.74 Cr
P/E (TTM)
63.48
EBITDA
₹3.30 Cr
Return on Equity
2.37%
Debt to Equity
0.2
Book Value
₹11.46
EPS (TTM)
₹0.77
52W High
₹52.00
52W Low
₹16.70

Price-based figures as of 28 Oct 2026, 15:30 IST · EPS basis: Standalone · TTM

Peer Comparison

Healthcare › Pharmaceuticals

Sun Pharma
₹1,767.6035.064,24,106 Cr5.070.91%13.79%17.94%61,848 Cr12,117 Cr
Divis Laboratories
₹9,659.0087.672,56,416 Cr15.300.32%15.32%18.96%11,682 Cr2,925 Cr
Torrent Pharmaceuticals
₹4,609.6072.361,75,334 Cr9.540.82%12.16%9.06%17,058 Cr2,156 Cr
Laurus Labs
₹2,187.10108.061,18,172 Cr22.300.09%16.38%19.67%7,323 Cr1,090 Cr
Zydus Life Science
₹1,181.0026.281,17,805 Cr4.350.09%16.99%19.24%28,515 Cr4,593 Cr
Dr Reddys Laboratories
₹1,338.4034.661,11,714 Cr2.880.61%10.87%13.94%34,247 Cr3,184 Cr
Cipla
₹1,362.2032.641,10,046 Cr3.110.96%11.21%14.88%28,589 Cr3,356 Cr
Veerhealth Care (this company)
—63.4898 Cr4.270.00%2.37%5.40%53 Cr2 Cr
Median 8 companies₹1,767.6049.271,17,988 Cr4.710.47%12.98%16.41%22,787 Cr3,055 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

58 Good
Overall score

Data confidence 100/100

Category scores

Quality Good 61
Returns, margins, earnings quality 22% weight
Valuation Poor 32
Cheap vs sector & own history 24% weight
Growth Strong 99
Sales & profit trajectory 9% weight
Financial Health Average 50
Solvency, leverage, coverage 9% weight
Momentum Strong 99
Trend strength, vol-adjusted 12% weight
Ownership Average 50
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

2
  • Company is expected to give good quarter
  • Company's working capital requirements have reduced from 142 days to 51.2 days

Weaknesses

5
  • Stock is trading at 4.30 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Promoter holding is low: 31.9%
  • Company has a low return on equity of 2.22% over last 3 years.
  • Debtor days have increased from 79.6 to 109 days.

Technical Indicators

Oscillators

Bearish

Bearish
2
Neutral
6
Bullish
1

Overall

Bearish

Bearish
7
Neutral
6
Bullish
6

Moving Averages

Neutral

Bearish
5
Neutral
0
Bullish
5

Growth Rate

Revenue Growth
86.03% higher than 3Y

change over 1 year

Net Income Growth
25% higher than 3Y

change over 1 year

Cash Flow Change
-7.1%

change over 1 year

EBITDA Margin Change
-2.2%

change over 1 year Operating margin 7.66% · Jun 2026

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
3.58
3.83
2.87
3.37
2.06
5.15
3.84
5.62
4.49
3.98
7.26
16.76
24.93
Expenses
3.15
3.62
2.7
3.2
2.08
4.67
3.69
5.78
4.52
3.45
6.02
16.03
23.02
Operating Profit
0.43
0.21
0.17
0.17
-0.02
0.48
0.15
-0.16
-0.03
0.53
1.24
0.73
1.91
OPM %
12.01%
5.48%
5.92%
5.04%
-0.97%
9.32%
3.91%
-2.85%
-0.67%
13.32%
17.08%
4.36%
7.66%
Other Income
0.15
0.42
0.24
0.17
0.36
0.25
0.18
0.43
0.65
0.23
-0.29
-0.09
0.16
Interest
0
0
0
0
0
0.11
0.01
0.14
0.1
0.1
0.1
0.11
0.23
Depreciation
0.18
0.18
0.18
0.18
0.19
0.2
0.25
0.26
0.28
0.31
0.35
0.35
0.36
PBT
0.4
0.45
0.23
0.16
0.15
0.42
0.07
-0.13
0.24
0.35
0.5
0.18
1.48
Tax %
15%
13.33%
17.39%
443.75%
20%
28.57%
0%
-23.08%
0%
25.71%
18%
294.44%
16.89%
Net Profit
0.34
0.39
0.19
-0.55
0.12
0.3
0.07
-0.1
0.24
0.25
0.4
-0.35
1.23
EPS (₹)
0.17
0.2
0.1
-0.28
0.06
0.15
0.04
-0.05
0.12
0.13
0.2
-0.18
0.62
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
1.33
2.14
1.89
5.17
5.98
11.72
10.62
9.64
13.28
13.22
16.87
32.48
52.93
Expenses
1.48
2.16
2.25
5.29
5.54
11.04
10.56
10.46
12.78
12.61
16.1
30.02
48.52
Operating Profit
-0.15
-0.02
-0.36
-0.12
0.44
0.68
0.06
-0.82
0.5
0.61
0.77
2.46
4.41
OPM %
-11.28%
-0.93%
-19.05%
-2.32%
7.36%
5.8%
0.56%
-8.51%
3.77%
4.61%
4.56%
7.57%
8.33%
Other Income
0.48
0.38
0.72
0.72
0.29
0.48
1.2
1.67
1.24
1.39
1.02
0.49
0.01
Interest
0.06
0.13
0.1
0.07
0.03
0.19
0.22
0.09
0
0.01
0.26
0.4
0.54
Depreciation
0.11
0.21
0.23
0.27
0.32
0.32
0.47
0.52
0.62
0.71
0.91
1.29
1.37
PBT
0.16
0.02
0.03
0.26
0.38
0.65
0.57
0.24
1.12
1.28
0.62
1.26
2.51
Tax %
62.5%
100%
33.33%
42.31%
57.89%
50.77%
35.09%
129.17%
-41.07%
68.75%
37.1%
56.35%
—
Net Profit
0.06
0.01
0.02
0.14
0.16
0.32
0.38
-0.07
1.58
0.41
0.39
0.54
1.53
EPS (₹)
0.04
0.01
0.01
0.1
0.12
0.23
0.27
-0.05
0.79
0.21
0.2
0.27
0.77
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
6.93
6.93
6.93
6.93
6.93
6.93
6.93
6.93
10
20
20
20
Reserves
5.86
5.88
5.92
6.17
6.35
6.82
7.11
7.02
11.43
1.84
2.22
2.92
Borrowings
1.01
1.08
-0.17
1.21
0.94
2.48
1.73
0
0
0
4.91
4.58
Other Liabilities
0.24
0.23
0.37
0.42
1.94
1.76
2.96
6.2
3.82
6.28
6.65
16.67
Total Liabilities
14.04
14.12
13.05
14.73
16.16
17.99
18.73
20.15
25.25
28.12
33.78
44.17
Fixed Assets
2.07
2.71
2.52
5.54
5.46
9.45
9.48
10.54
12.01
11.97
19.87
23.43
CWIP
0
0
0
0.24
2.19
0
0
0
0
0
0
0
Investments
0
0
0
0
0
0
0
0
0
0
0
0
Other Assets
11.97
11.41
10.53
8.95
8.51
8.54
9.25
9.61
13.24
16.15
13.91
20.74
Total Assets
14.04
14.12
13.05
14.73
16.16
17.99
18.73
20.15
25.25
28.12
33.78
44.17
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
-3.73
0
1.69
1.76
1.98
-0.36
1
1.81
-0.7
2.9
4.51
4.19
Investing
3.85
-0.01
-0.44
-3.02
-1.9
-1.67
-0.09
-1.09
-1.79
-0.28
-8.2
-4.43
Financing
0
0
-1.33
1.31
0.02
1.85
-0.83
-0.42
5.69
-5.99
4.61
-0.46
Net Cash Flow
0.12
-0.01
-0.08
0.06
0.1
-0.17
0.09
0.3
3.21
-3.37
0.92
-0.7
Free Cash Flow
-1.02
-0.76
1.66
-1.78
-0.21
-2.48
0.5
0.23
-2.79
2.22
-4.3
-0.67
CFO/EBITDA
2,533
50
-253
-1,550
480
-44
2,050
-226
-100
523
597
179
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
255
152
118
64.95
45.17
29.27
52.93
58.31
50.57
108
21.2
109
Inventory Days
230
444
477
93.49
77.82
54.35
76.21
103
103
55.97
78.12
67.26
Days Payable
55
31.74
68.63
18.9
145
37.12
42.24
112
21.75
86.35
83.89
183
Cash Conversion Cycle
430
564
526
140
-22.46
46.51
86.9
48.61
132
77.85
15.44
-6.47
Working Capital Days
2,121
1,049
1,597
394
8.55
145
177
128
158
289
85.25
51.24
ROCE %
-0.15%
1.08%
0.98%
2.45%
2.87%
5.52%
4.94%
2.22%
6.33%
5.96%
3.59%
7.21%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Veerhealth Care insights

60 extracted metrics + investor summaries across FY15–FY27.

Shareholding Pattern

Public55.28%Others12.85%Promot.31.88%As ofSep 2026

Documents

1
Concall - Jun 2026 Jun 2026
2
Concall - Feb 2026 Feb 2026
3
Concall - Feb 2026 Feb 2026
4
Concall - Aug 2025 Aug 2025
5
Concall - Sep 2024 Sep 2024

Frequently Asked Questions about Veerhealth Care

What does Veerhealth Care Ltd do?
Incorporated in 1992, Veer Healthcare Ltd is in the business of trading, manufacturing and marketing research based ayurvedic medicines[1]
Where is Veerhealth Care Ltd (VEERHEALTH) listed?
Veerhealth Care Ltd trades under code 511523 on the BSE.
Which sector does Veerhealth Care Ltd belong to?
Veerhealth Care Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the market capitalisation of Veerhealth Care Ltd?
Veerhealth Care Ltd has a market capitalisation of ₹97.74 Cr as of 28 Oct 2026, which places it in the Small Cap band.
What is the PE ratio of Veerhealth Care Ltd?
Veerhealth Care Ltd trades at a PE ratio of 63.48 as of 28 Oct 2026, on earnings per share of ₹0.77, against a book value of ₹11.46 per share.
What is the 52-week high and low of Veerhealth Care Ltd?
Over the last 52 weeks Veerhealth Care Ltd has traded between ₹16.7 and ₹52 as of 28 Oct 2026.
What is the Return on Equity (ROE) of Veerhealth Care Ltd?
Veerhealth Care Ltd reported a return on equity of 2.37%. Its debt-to-equity ratio is 0.20.

Company Information

Incorporated in 1992, Veer Healthcare Ltd is in the business of trading, manufacturing and marketing research based ayurvedic medicines[1]

Website veerhealthcare.net
Face Value ₹ 10
Shares Outstanding 1,99,95,956

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/511523.md for Veerhealth Care Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Pharma stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month